Cycles of Enthusiasm, Reversal, and Revival in Medical Practice
SHARE | PRINT | EMAIL
[Sassy_Social_Share]
It’s hard to generalize, but when reversals are based on better quality evidence, we should presume they’re in the public interest. However, when they are based... Read more.
Malflusiva and the Wheeking Guinea Pigs
SHARE | PRINT | EMAIL
[Sassy_Social_Share]
The most infuriating part of the VRBPAC meeting was that the members actually acknowledged and discussed some of these concerns, but instead of postponing its recommendation,... Read more.
The Trouble with Cancer Screening in Healthy Adults
SHARE | PRINT | EMAIL
[Sassy_Social_Share]
We framed screening as prevention; instead, it has become a factory of medicalization, anxiety, and expense. If medicine’s moral compass is to be preserved, we... Read more.
Less Is More in Medicine
SHARE | PRINT | EMAIL
[Sassy_Social_Share]
We need to be asking questions about whether sending more of our collective wealth towards our healthcare system is producing good returns. We might expect that... Read more.
The Biggest Breast Cancer Advance in the Last Twenty Years
SHARE | PRINT | EMAIL
[Sassy_Social_Share]
Some clinicians and public-health researchers would argue that the media narrative minimizes known and proven downsides of these drugs, often trivializing or ignoring... Read more.
The Ozempic Paradox
SHARE | PRINT | EMAIL
[Sassy_Social_Share]
The same week that our drug regulator, Health Canada, approved the first generic version of semaglutide—the active ingredient in weight-loss drug Ozempic—a major... Read more.
Let’s Save Our Doctors’ Time for Sick People
SHARE | PRINT | EMAIL
[Sassy_Social_Share]
What would a smarter approach look like? Our health systems need to create clear, evidence-based thresholds for when to recommend screening or primary prevention... Read more.
You Can’t Unsee This
SHARE | PRINT | EMAIL
[Sassy_Social_Share]
This latest dispatch from the world of pharmaceutical safety comes from that drug class that is a gift that keeps on giving, the blockbuster weight-loss drugs known... Read more.
What Does the Fifth Doctor Think about Ozempic?
SHARE | PRINT | EMAIL
[Sassy_Social_Share]
This is a slightly shortened version of a New York Times article where Katrin Bennhold interviews Dani Blum of the Times’ “Well Team” about Ozempic and GLP-1... Read more.
Book Review of No More Tears: the Dark Secrets of Johnson & Johnson
SHARE | PRINT | EMAIL
[Sassy_Social_Share]
Johnson & Johnson’s reputation comes under fire in Gardiner Harris’s new book No More Tears: The Dark Secrets of Johnson & Johnson. He delivers an impressively-researched... Read more.
The Seven Deadly Sins of Weight Loss Drugs
SHARE | PRINT | EMAIL
[Sassy_Social_Share]
Gaining too much weight so that it impairs your health is overwhelmingly linked to diet, exercise, and ultra-processed food, yet these behavioural, social, and environmental... Read more.
The Dauntless Dane Exposes the Dark Side of HPV Vaccines
SHARE | PRINT | EMAIL
[Sassy_Social_Share]
The real truth about vaccines for HPV cannot be derived from conflicted researchers, shoddy and biased research, or lame regulatory mechanisms. It comes from lawyers... Read more.